These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 3004800)

  • 21. Prolonged remission of severe Cushing syndrome without adrenalectomy in an infant with McCune-Albright syndrome.
    Gillis D; Rösler A; Hannon TS; Koplewitz BZ; Hirsch HJ
    J Pediatr; 2008 Jun; 152(6):882-4, 884.e1-4. PubMed ID: 18492536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregnancy complicated by Cushing's syndrome: potential hazard of metyrapone therapy. Case report.
    Connell JM; Cordiner J; Davies DL; Fraser R; Frier BM; McPherson SG
    Br J Obstet Gynaecol; 1985 Nov; 92(11):1192-5. PubMed ID: 4063238
    [No Abstract]   [Full Text] [Related]  

  • 23. [Functional evaluation of the pituitary gland with the metyrapone test and determination of ACTH in the blood].
    Isidori A; Frajese G; Dondero F
    Folia Endocrinol; 1967 Apr; 20(2):223-33. PubMed ID: 4294756
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prolonged remission in Cushing's syndrome following treatment with ortho-para-dichlordiphenyldichlorethane].
    Kirkegaard C; Kolendorf K
    Ugeskr Laeger; 1974 Jun; 136(25):1389-91. PubMed ID: 4366485
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of aminoglutethimide in the treatment of Cushing's syndrome].
    Jacobelli A; Borgia MC; Borgia C; Sellini M
    Minerva Med; 1974 Jan; 65(3):156-62. PubMed ID: 4370585
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of metyrapone to treat pituitary-dependent hyperadrenocorticism in a cat with large cutaneous wounds.
    Daley CA; Zerbe CA; Schick RO; Powers RD
    J Am Vet Med Assoc; 1993 Mar; 202(6):956-60. PubMed ID: 8468223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxyphil metaplasia of adrenal cortex secondary to metyrapone therapy.
    Suvarna SK; Stephenson TJ
    Histopathology; 2001 Nov; 39(5):546-7. PubMed ID: 11737320
    [No Abstract]   [Full Text] [Related]  

  • 28. [Diagnosis and therapy of endogenic hypercortisolism (Cushing's syndrome)].
    Meng W; Meng S
    Z Arztl Fortbild (Jena); 1972 Oct; 66(20):1025-31. PubMed ID: 4346727
    [No Abstract]   [Full Text] [Related]  

  • 29. An unusual profile of endocrine study in a patient with pre-Cushing's syndrome.
    Kodama C; Nakada T; Sasagawa I; Ishigooka M; Yamaguchi T; Suzuki H
    Int Urol Nephrol; 1993; 25(6):517-24. PubMed ID: 8175270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Importance of the study of corticotropin circadian rhythm in the functional symptomatology of the ACTH-adrenal axis].
    Angeli A; Boccuzzi G; Frairia R; Bisbocci D
    Minerva Med; 1974 Jun; 65(46):2499-512. PubMed ID: 4367702
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of stimulation and suppression tests in the etiological diagnosis of Cushing's syndrome.
    Weiss ER; Rayyis SS; Nelson DH; Bethune JE
    Ann Intern Med; 1969 Nov; 71(5):941-9. PubMed ID: 4311765
    [No Abstract]   [Full Text] [Related]  

  • 32. [2 cases of Cushing's disease with a hypokalemic alkalosis syndrome].
    Guinet P; Mornex R; Revol A; Bertrand J; Veyrat A; Dorsit G
    Rev Lyon Med; 1967 Nov; 16(17):696-702. PubMed ID: 5623601
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pituitary corticotropin function in hypertonic obesity "with rose striae"].
    Dondero F; Negro F; Isidori A
    Folia Endocrinol; 1970 Feb; 23(1):1-8. PubMed ID: 4321908
    [No Abstract]   [Full Text] [Related]  

  • 34. A new phenomenon of usefulness in the radioimmunoassay of plasma adrenocorticotropic hormone.
    Matsukura S; West CD; Ichikawa Y; Jubiz W; Harada G; Tyler FH
    J Lab Clin Med; 1971 Mar; 77(3):490-500. PubMed ID: 4324264
    [No Abstract]   [Full Text] [Related]  

  • 35. Measurement of pituitary hormones: clinical applications. 2. Corticotrophin.
    Donald RA; Espiner EA; Beaven DW
    N Z Med J; 1972 Jun; 75(481):342-7. PubMed ID: 4344180
    [No Abstract]   [Full Text] [Related]  

  • 36. The assay of ACTH in plasma.
    Nelson DH; Ruhmann-Wennhold A
    Mt Sinai J Med; 1973; 40(3):315-22. PubMed ID: 4351490
    [No Abstract]   [Full Text] [Related]  

  • 37. Metyrapone tests in patients with panic disorder.
    Kellner M; Schick M; Yassouridis A; Struttmann T; Wiedemann K; Alm B
    Biol Psychiatry; 2004 Dec; 56(11):898-900. PubMed ID: 15576069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocrine and other physiological derangements following long-term glucocorticoid therapy.
    Liddle GW
    Chronobiologia; 1974 Sep; 1 Suppl 1():237-47. PubMed ID: 4377959
    [No Abstract]   [Full Text] [Related]  

  • 39. Metyrapone-induced alopecia.
    Harries-Jones R; Overstall P
    Postgrad Med J; 1990 Jul; 66(777):584. PubMed ID: 2217026
    [No Abstract]   [Full Text] [Related]  

  • 40. Alopecia associated with long-term metyrapone use.
    Harris PL
    Clin Pharm; 1986 Jan; 5(1):66-8. PubMed ID: 3004800
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.